1. Home
  2. KR vs TAK Comparison

KR vs TAK Comparison

Compare KR & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kroger Company (The)

KR

Kroger Company (The)

HOLD

Current Price

$62.55

Market Cap

44.8B

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$14.93

Market Cap

43.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KR
TAK
Founded
1883
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.8B
43.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KR
TAK
Price
$62.55
$14.93
Analyst Decision
Buy
Analyst Count
13
0
Target Price
$73.46
N/A
AVG Volume (30 Days)
7.3M
2.6M
Earning Date
12-04-2025
01-29-2026
Dividend Yield
2.23%
3.56%
EPS Growth
N/A
N/A
EPS
1.16
0.14
Revenue
$147,225,000,000.00
$29,846,840,032.00
Revenue This Year
$4.12
N/A
Revenue Next Year
$2.81
$0.59
P/E Ratio
$54.11
$106.44
Revenue Growth
N/A
N/A
52 Week Low
$58.12
$12.80
52 Week High
$74.90
$15.69

Technical Indicators

Market Signals
Indicator
KR
TAK
Relative Strength Index (RSI) 42.84 67.77
Support Level $61.97 $14.43
Resistance Level $63.90 $14.66
Average True Range (ATR) 1.37 0.16
MACD -0.08 0.05
Stochastic Oscillator 23.08 90.00

Price Performance

Historical Comparison
KR
TAK

About KR Kroger Company (The)

Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of over 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Share on Social Networks: